FindTrial
Sign In

umbilical cord mesenchymal stem cell

BIOLOGICAL9 trials

Sponsors

Acibadem University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Sclnow Biotechnology Co., Ltd., Indonesia University, Nguyen Ton Ngoc Huynh

Conditions

Acute Respiratory Distress SyndromeAcute-On-Chronic Liver FailureAging ProblemsDiabetesDuchenne Muscular DystrophyInflammatory DiseaseKetoacidosis, DiabeticLipid Metabolism Disorders

Early Phase 1

Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management
NCT03800810
Indonesia UniversityOsteoarthritis, Knee
Start: 2015-05-31End: 2019-05-31Target: 9Updated: 2019-01-23

Phase 1

Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy
NCT02285673
Acibadem UniversityDuchenne Muscular Dystrophy
Start: 2013-11-30End: 2015-11-30Target: 10Updated: 2014-11-07
Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation
Active, not recruitingNCT06448052
Nguyen Ton Ngoc HuynhAging Problems, Diabetes, Inflammatory Disease +2
Start: 2023-11-01End: 2026-10-30Target: 72Updated: 2024-06-07
Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients
RecruitingNCT06492798
Changhai HospitalLong COVID, Post-Acute COVID-19 Syndrome
Start: 2023-09-01End: 2026-08-31Target: 76Updated: 2024-07-09
Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS
Not yet recruitingNCT06505941
Southeast University, ChinaAcute Respiratory Distress Syndrome
Start: 2024-07-20End: 2027-02-20Target: 60Updated: 2024-07-17
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)
Not yet recruitingNCT07131540
Institute of Liver and Biliary Sciences, IndiaAcute-On-Chronic Liver Failure
Start: 2026-01-31End: 2031-12-31Target: 10Updated: 2025-08-28

Phase 2

Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis
NCT02763423
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolKetoacidosis, Diabetic
Start: 2009-01-31End: 2019-12-31Target: 30Updated: 2016-05-05
Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia
Not yet recruitingNCT03378414
Sclnow Biotechnology Co., Ltd.Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3 +1
Start: 2025-12-31End: 2026-12-31Target: 45Updated: 2025-12-04

Phase 3

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial
Not yet recruitingNCT07075315
Institute of Liver and Biliary Sciences, IndiaAcute-On-Chronic Liver Failure
Start: 2028-01-31End: 2031-12-31Target: 100Updated: 2025-08-17

Related Papers

Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes
Stem Cell Research & Therapy2022-08-0842 citations